Aortic Valve Surgery

Aortic Valve Surgery is a critical subspecialty within cardiothoracic practice dedicated to the repair and replacement of the aortic valve in patients with stenosis, regurgitation, congenital abnormalities, or degenerative disease. Featured prominently in a global Surgical Science Conference, this session examines contemporary operative strategies, technological innovations, and long-term outcome optimization in aortic valve replacement and reconstructive valve procedures. As cardiovascular disease remains a leading cause of morbidity worldwide, advancements in valve interventions continue to redefine surgical standards.

This field encompasses traditional open surgical replacement, valve-sparing root procedures, minimally invasive approaches, and hybrid techniques integrating transcatheter technologies. Surgeons must carefully evaluate anatomical considerations, ventricular function, comorbid conditions, and patient age when selecting between mechanical and bioprosthetic valves or considering reconstructive repair. Enhanced imaging modalities such as transesophageal echocardiography and cardiac CT scanning now provide detailed preoperative mapping that guides precise intervention planning.

Valve repair strategies are gaining increasing attention, particularly in younger patients and those with aortic root dilation or congenital abnormalities. Techniques such as cusp reconstruction and valve-sparing root replacement aim to preserve native valve function while ensuring durability. Meanwhile, minimally invasive sternotomy and right anterior thoracotomy approaches have reduced operative trauma and improved recovery times without compromising precision. Advances in cardiopulmonary bypass protocols and myocardial protection strategies have further strengthened intraoperative safety and postoperative recovery.

This session also explores postoperative management, anticoagulation considerations, and long-term surveillance of prosthetic and repaired valves. Prevention of complications—including prosthetic valve dysfunction, endocarditis, and thromboembolic risk—remains central to improving outcomes. Emerging research in tissue-engineered valves, biomaterial longevity, and patient-specific hemodynamic modeling continues to influence the future direction of cardiac valve procedures.

By integrating surgical expertise with cardiology collaboration, advanced imaging, and registry-based outcomes research, modern valve interventions are achieving improved survival rates and enhanced quality of life. This session provides a comprehensive platform to examine evolving techniques, minimally invasive solutions, and durable valve technologies shaping the future of cardiac surgery.